Asset Allocation

As of January 31, 2026.
Type % Net
Cash 1.24%
Stock 23.62%
Bond 71.84%
Convertible 0.00%
Preferred 2.64%
Other 0.66%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.63%    % Emerging Markets: 0.38%    % Unidentified Markets: 0.99%

Americas 94.29%
94.07%
Canada 85.29%
United States 8.78%
0.23%
As of January 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 4.29%
United Kingdom 1.86%
2.28%
Denmark 0.00%
France 0.73%
Germany 0.01%
Ireland 0.17%
Italy 0.17%
Netherlands 0.41%
Sweden 0.76%
Switzerland 0.02%
0.13%
Poland 0.13%
0.01%
Israel 0.01%
Greater Asia 0.43%
Japan 0.32%
0.02%
Australia 0.02%
0.08%
Singapore 0.08%
0.00%
Unidentified Region 0.99%

Bond Credit Quality Exposure

AAA 30.12%
AA 12.39%
A 32.96%
BBB 15.14%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.24%
Not Available 8.14%
Short Term 0.00%
As of January 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
13.47%
Materials
0.27%
Consumer Discretionary
3.83%
Financials
7.46%
Real Estate
1.91%
Sensitive
8.97%
Communication Services
0.93%
Energy
0.00%
Industrials
4.37%
Information Technology
3.67%
Defensive
2.70%
Consumer Staples
1.75%
Health Care
0.53%
Utilities
0.42%
Not Classified
74.86%
Non Classified Equity
0.50%
Not Classified - Non Equity
74.36%
As of January 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of January 31, 2026
Type % Net
Government 14.99%
Corporate 45.40%
Securitized 1.54%
Municipal 26.38%
Other 11.69%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.15%
Less than 1 Year
0.15%
Intermediate
63.93%
1 to 3 Years
12.35%
3 to 5 Years
13.26%
5 to 10 Years
38.33%
Long Term
31.73%
10 to 20 Years
15.43%
20 to 30 Years
12.90%
Over 30 Years
3.40%
Other
4.18%
As of January 31, 2026
View Bond Maturity Exposure
Start Trial